WO2010125408A3 - Prostata-norm rectal suppositories for the treatment of prostatitis - Google Patents

Prostata-norm rectal suppositories for the treatment of prostatitis Download PDF

Info

Publication number
WO2010125408A3
WO2010125408A3 PCT/GE2010/000002 GE2010000002W WO2010125408A3 WO 2010125408 A3 WO2010125408 A3 WO 2010125408A3 GE 2010000002 W GE2010000002 W GE 2010000002W WO 2010125408 A3 WO2010125408 A3 WO 2010125408A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
prostatitis
prostata
norm
rectal suppositories
Prior art date
Application number
PCT/GE2010/000002
Other languages
French (fr)
Other versions
WO2010125408A2 (en
Inventor
Giorgi Gogbaidze
Natalia Gogbaidze
Original Assignee
Giorgi Gogbaidze
Natalia Gogbaidze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giorgi Gogbaidze, Natalia Gogbaidze filed Critical Giorgi Gogbaidze
Publication of WO2010125408A2 publication Critical patent/WO2010125408A2/en
Publication of WO2010125408A3 publication Critical patent/WO2010125408A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention refers to medicine, in particular to urology and concerns rectal suppositories that are used for the treatment of prostatitis. The technical result of this invention is widening of assortment of medicinal means for treatment of prostatitis and the reduction of treatment duration. The technical result is achieved in that suppositories contain dipotassium glycyrrhizinate, chymotrypsin in crystalline form, tea tree oil (pharmaceutical form) and diphyllic base.
PCT/GE2010/000002 2009-05-01 2010-04-23 Prostata-norm rectal suppositories for the treatment of prostatitis WO2010125408A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GEAP200911241A GEP20115319B (en) 2009-05-01 2009-05-01 Rectal suppositories for treatment of prostate “prostate-norm”
GEAP2009011241 2009-05-01

Publications (2)

Publication Number Publication Date
WO2010125408A2 WO2010125408A2 (en) 2010-11-04
WO2010125408A3 true WO2010125408A3 (en) 2011-03-03

Family

ID=43478016

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GE2010/000002 WO2010125408A2 (en) 2009-05-01 2010-04-23 Prostata-norm rectal suppositories for the treatment of prostatitis

Country Status (2)

Country Link
GE (1) GEP20115319B (en)
WO (1) WO2010125408A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535704A1 (en) * 1991-10-04 1993-04-07 Sanwa Kagaku Kenkyusho Co., Ltd. Glycyrrhizin suppository
CN1134293A (en) * 1995-04-28 1996-10-30 丁志敏 Producing method of Chinese traditional medicine and western medicine combination injection for prostatitis and hyperplasia of prostate
CN1326780A (en) * 2001-06-02 2001-12-19 辛耀禄 Medicinal capsule for cuirng male sterility and its preparing process
CN1520842A (en) * 2003-01-29 2004-08-18 谢殿左 Liposoluble suppository for treating prostatitis
CN1562218A (en) * 2004-04-13 2005-01-12 云大科技股份有限公司 Medication combination of compound tea tree oil for preventing or curing inflammation of human genital tract
CN1736447A (en) * 2005-07-28 2006-02-22 谢作印 Compound essential oil for treating prostatitis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535704A1 (en) * 1991-10-04 1993-04-07 Sanwa Kagaku Kenkyusho Co., Ltd. Glycyrrhizin suppository
CN1134293A (en) * 1995-04-28 1996-10-30 丁志敏 Producing method of Chinese traditional medicine and western medicine combination injection for prostatitis and hyperplasia of prostate
CN1326780A (en) * 2001-06-02 2001-12-19 辛耀禄 Medicinal capsule for cuirng male sterility and its preparing process
CN1520842A (en) * 2003-01-29 2004-08-18 谢殿左 Liposoluble suppository for treating prostatitis
CN1562218A (en) * 2004-04-13 2005-01-12 云大科技股份有限公司 Medication combination of compound tea tree oil for preventing or curing inflammation of human genital tract
CN1736447A (en) * 2005-07-28 2006-02-22 谢作印 Compound essential oil for treating prostatitis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE TCM [online] SIPO; 19 December 2001 (2001-12-19), "A pharmaceutical capsule for the treatment of male infertility, and its preparation method", XP002611843, Database accession no. CN-01121358-A *
DATABASE TCM [online] SIPO; 22 February 2006 (2006-02-22), "A kind of compound essential oil for treating prostatitis", XP002611845, Database accession no. CN-200510028264-A *
DATABASE WPI Week 199803, Derwent World Patents Index; AN 1998-019316, XP002611844 *
DATABASE WPI Week 200479, Derwent World Patents Index; AN 2004-797039, XP002611842 *
DATABASE WPI Week 200532, Derwent World Patents Index; AN 2005-307013, XP002611846 *

Also Published As

Publication number Publication date
WO2010125408A2 (en) 2010-11-04
GEP20115319B (en) 2011-10-25

Similar Documents

Publication Publication Date Title
WO2013078402A3 (en) Tissue and stone removal device
UA106748C2 (en) Proline derivatives as cathepsin inhibitors
GB2485291B (en) Cannabidiol for use in the treatment of generalised and/or partial seizures
MA33894B1 (en) The operation of the treatment of perfridone
CR20110449A (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN AND PROCESSES TO PRODUCE THE SAME
PH12013502370A1 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
MX2012001974A (en) Biaryl compounds and methods of use thereof.
MX2011007930A (en) Crystalline insulin-conjugates.
WO2011037643A3 (en) Compositions and methods for detecting and treating prostate carcinoma
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
WO2012046030A3 (en) Phosphodiesterase inhibitors
SG179566A1 (en) Hcv protease inhibitors
MY165826A (en) Pharmaceutical composition
WO2011130537A3 (en) Pharmaceutical compositions and methods for digesting atherosclerotic plaques
WO2010018526A3 (en) Composition for treatment of the skin
AP2012006292A0 (en) Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection.
WO2011009890A3 (en) Use of azabicycloalkyl derivatives or pyrrolidine - 2 - one derivatives for the treatment or prevention of ataxia
EP2411042A4 (en) Tissue kallikrein for the treatment of pancreatic -cell dysfunction
WO2013052006A8 (en) Parp-1 inhibitors
WO2010065861A3 (en) Inhibitors of bace 1 and methods for treating alzheimer's disease
WO2011029639A3 (en) Compounds and methods for treating neoplasia
WO2008050133A3 (en) Inhibition of beta-amyloid aggregation
WO2008042968A3 (en) Di-fluoro containing compounds as cysteine protease inhibitors
EP2445872A4 (en) Cathepsin cysteine protease inhibitors for the treatment of various diseases
WO2010125408A3 (en) Prostata-norm rectal suppositories for the treatment of prostatitis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10719773

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10719773

Country of ref document: EP

Kind code of ref document: A2